SMARCC1 and prostate carcinoma: Increased expression of BAF155 mRNA has been found in colorectal cancer, prostate cancer, and cervical intraepithelial neoplasia [148–151], and loss of BAF155 is seen in a variety of human cancers, including the A427 lung cancer cell line [152].